Fabian Tenenbaum

2019

In 2019, Fabian Tenenbaum earned a total compensation of $1.4M as Chief Executive Officer at Bellerophon Therapeutics, a 40% decrease compared to previous year.

Compensation breakdown

Bonus$372,000
Option Awards$585,704
Salary$425,492
Other$16,800
Total$1,399,996

Tenenbaum received $585.7K in option awards, accounting for 42% of the total pay in 2019.

Tenenbaum also received $372K in bonus, $425.5K in salary and $16.8K in other compensation.

Rankings

In 2019, Fabian Tenenbaum's compensation ranked 7,671st out of 13,971 executives tracked by ExecPay. In other words, Tenenbaum earned more than 45.1% of executives.

ClassificationRankingPercentile
All
7,671
out of 13,971
45th
Division
Manufacturing
2,989
out of 5,695
48th
Major group
Chemicals And Allied Products
1,121
out of 2,194
49th
Industry group
Drugs
955
out of 1,880
49th
Industry
Pharmaceutical Preparations
708
out of 1,392
49th
Source: SEC filing on April 23, 2020.

Tenenbaum's colleagues

We found two more compensation records of executives who worked with Fabian Tenenbaum at Bellerophon Therapeutics in 2019.

2019

Peter Fernandes

Bellerophon Therapeutics

Chief Regulatory and Safety Officer

2019

Assaf Korner

Bellerophon Therapeutics

Chief Financial Officer

News

You may also like